The biomarkers market is expanding due to rising demand for personalized medicine and early disease detection. Biomarkers are essential in drug discovery, diagnostics, and treatment monitoring. Growing cancer prevalence and technological advancements in genomics and proteomics are boosting investment and research, driving adoption across healthcare, pharmaceuticals, and clinical research sectors.

Read More: https://www.imarcgroup.com...